Late‑stage deals dominate startup funding in April to May

Seed-stage companies secured $52.2m as total investments reached $214m.

Late-stage deals were the dominant source of startup funding in Singapore, accounting for $157.8m, or 73.9%, of the $214m raised between 1 April and 31 May, according to Tracxn.

Seed-stage startups attracted $52.2m, representing 24.4% of total funding, whilst early-stage companies raised $3.7m for the period.

Amongst completed quarters, late-stage funding reached $2.4b in the first quarter (Q1) of 2026 and $460m in Q2 2025.

Seed-stage funding stood at $105.8m in Q1 2026 and $48.5m in Q2 2025, whilst early-stage funding totalled $459.6m and $218.1m, respectively.

The latest funding activity was led by Silicon Box’s $150m round, followed by Simple Chain at $15m, Biobot Surgical at $7.8m, Brano Therapeutics at $6.8m, and Atlas at $6m.